Prospective study of Foscarnet sodium administration for the prevention of HHV-6 encephalitis after hematopoietic stem cell transplantatio
Phase 1
- Conditions
- Patients with hematologic malignancies, transplanted unrelated cord blood (UCBT) or HLA-one haplotype mismatch graft from a relative (haplo SCT)
- Registration Number
- JPRN-UMIN000001346
- Lead Sponsor
- Cellular transplantation biology, Graduate School of Medical Science, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Hypersensitive for PFA 2. Existence of comorbid disease, grade 3 or more in CTCAE v3.0 (except renal insufficiency) 3. Existence of renal insufficiency, grade 2 or more in CTCAE v3.0 4. Unsuitable for enrollment judged by attending physian
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method